Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA GSK PHARMA SANOFI INDIA/
GSK PHARMA
 
P/E (TTM) x 30.6 62.0 49.4% View Chart
P/BV x 15.2 18.8 80.8% View Chart
Dividend Yield % 7.1 1.7 430.3%  

Financials

 SANOFI INDIA   GSK PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
GSK PHARMA
Mar-23
SANOFI INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs7,9391,684 471.5%   
Low Rs5,4541,231 443.2%   
Sales per share (Unadj.) Rs1,202.8191.9 626.7%  
Earnings per share (Unadj.) Rs269.535.9 751.3%  
Cash flow per share (Unadj.) Rs287.739.8 723.7%  
Dividends per share (Unadj.) Rs570.0032.00 1,781.3%  
Avg Dividend yield %8.52.2 387.6%  
Book value per share (Unadj.) Rs527.0102.9 512.2%  
Shares outstanding (eoy) m23.03169.41 13.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.67.6 73.3%   
Avg P/E ratio x24.940.6 61.2%  
P/CF ratio (eoy) x23.336.7 63.5%  
Price / Book Value ratio x12.714.2 89.7%  
Dividend payout %211.589.2 237.1%   
Avg Mkt Cap Rs m154,224246,858 62.5%   
No. of employees `000NANA-   
Total wages/salary Rs m4,0595,950 68.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,70132,517 85.2%  
Other income Rs m7301,007 72.5%   
Total revenues Rs m28,43133,524 84.8%   
Gross profit Rs m8,3498,033 103.9%  
Depreciation Rs m419658 63.7%   
Interest Rs m1718 93.8%   
Profit before tax Rs m8,6438,364 103.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4372,288 106.5%   
Profit after tax Rs m6,2066,076 102.1%  
Gross profit margin %30.124.7 122.0%  
Effective tax rate %28.227.4 103.1%   
Net profit margin %22.418.7 119.9%  
BALANCE SHEET DATA
Current assets Rs m36,12124,943 144.8%   
Current liabilities Rs m27,42513,264 206.8%   
Net working cap to sales %31.435.9 87.4%  
Current ratio x1.31.9 70.0%  
Inventory Days Days11797 119.9%  
Debtors Days Days17216 7.9%  
Net fixed assets Rs m12,1486,988 173.8%   
Share capital Rs m2301,694 13.6%   
"Free" reserves Rs m11,90615,735 75.7%   
Net worth Rs m12,13617,430 69.6%   
Long term debt Rs m00-   
Total assets Rs m48,27931,930 151.2%  
Interest coverage x509.4462.6 110.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.0 56.3%   
Return on assets %12.919.1 67.5%  
Return on equity %51.134.9 146.7%  
Return on capital %71.448.1 148.4%  
Exports to sales %14.10-   
Imports to sales %14.648.1 30.3%   
Exports (fob) Rs m3,904NA-   
Imports (cif) Rs m4,03715,630 25.8%   
Fx inflow Rs m3,9041,622 240.7%   
Fx outflow Rs m4,03715,630 25.8%   
Net fx Rs m-133-14,008 0.9%   
CASH FLOW
From Operations Rs m3,9874,842 82.3%  
From Investments Rs m6,5098,079 80.6%  
From Financial Activity Rs m-15,827-15,433 102.6%  
Net Cashflow Rs m-5,331-2,512 212.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 28.8 11.6 248.9%  
FIIs % 6.3 2.9 215.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.0 158.4%  
Shareholders   62,870 114,663 54.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs GSK Pharma Share Price Performance

Period Sanofi India GSK Pharma S&P BSE HEALTHCARE
1-Day 0.69% 2.84% 1.20%
1-Month -9.32% -10.15% -0.73%
1-Year 42.52% 52.00% 61.85%
3-Year CAGR 0.51% 10.74% 18.17%
5-Year CAGR 6.78% 8.35% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.